Release of Organic Components of a GIOMER in Non-carious Cervical Lesion Restorations
NCT ID: NCT03637946
Last Updated: 2020-02-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
10 participants
INTERVENTIONAL
2018-06-01
2020-02-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Evaluation of a New Giomer Restorative System in Class V Restorations
NCT03153969
18-Month Clinical Evaluation of Self-Adhesive Flowable Giomer Compared to Conventional Flowable Giomer in Carious Cervical Lesions: A Randomized Clinical Trial
NCT06946134
The Effectiveness RMGI and Giomer, Individually and Combined Anterior Cervical Caries
NCT06901453
Evaluation of Two Resin Composites and Two Adhesives for a Novel Restorative Protocol to Treat Cervical Lesions
NCT03215615
The Influence of Non-Carious Cervical Lesions on Root Coverage
NCT06438094
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
SHOFU Beautifil II LS
Experimental: SHOFU Beautifil II LS Restorative system FL-Bond II (self-etching adhesive system)/ Beautifil II (composite restorative)
Device: SHOFU beautifil II LS
Restorative system FL-Bond II (self-etching adhesive system)/ beautifil II (composite restorative) were used following manufacturer's instructions
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Device: SHOFU beautifil II LS
Restorative system FL-Bond II (self-etching adhesive system)/ beautifil II (composite restorative) were used following manufacturer's instructions
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* With good oral hygiene;
* Absent irreversible pulpal alteration;
* With the presence of a non-carious cervical lesion (LCNCs) that needs to be restored. This lesion should be non-carious, non-retentive, with at least 1 mm and up to 3 mm depth, should involve both enamel and dentin of vital teeth without mobility, and present hypersensitivity;
* Presence a natural tooth of the same position of the restored tooth, but in the opposite arch of the same jaw to be considered for the positive control;
* Periodontal parameters : Depth Probing (PS), Visible Plaque Index (IPV), Gingival Index (GI) and Probing Bleed Index (SS). The normal included were: PS = 1 to 3 mm, GI = 0, IPV = score 0 e SS = score 0.
* Individuals with clinical signs of parafunctional habits;
* Smoking;
* Individuals who have performed other restorations in the last 12 months;
* Pregnant women and infants;
* Periodontal sites that presented bleeding during crevicular fluid collection or sites that prevent proper collection of clinical parameters.
Exclusion Criteria
* In the use of antibiotics and anti-inflammatories in the last three months;
18 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
OTHER_GOV
Fundação de Amparo à Pesquisa do estado de Minas Gerais
OTHER
Federal University of Minas Gerais
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Tassiana Cançado Melo Sá
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Federal University Of Minas Gerais
Belo Horizonte, Minas Gerais, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RBR-8m8cf2
Identifier Type: REGISTRY
Identifier Source: secondary_id
FUMinasGerais02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.